Recap: Arcus Biosciences Q2 Earnings

Recap: Arcus Biosciences Q2 Earnings

Arcus Biosciences RCUS reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:03 PM.

Here's what investors need to know about the announcement.

Earnings

Arcus Biosciences beat estimated earnings by 1.06%, reporting an EPS of $-0.93 versus an estimate of $-0.94.

Revenue was up $17.30 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.65 which was followed by a 11.67% increase in the share price the next day.

Here's a look at Arcus Biosciences's past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.31 -0.74 -1.08 -0.88
EPS Actual -0.96 3.71 -1.11 -1.09
Revenue Estimate 79.42M 39.39M 9.40M 13.05M
Revenue Actual 18.00M 354.50M 9.46M 9.46M

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.31 -0.74 -1.08 -0.88
EPS Actual -0.96 3.71 -1.11 -1.09
Revenue Estimate 79.42M 39.39M 9.40M 13.05M
Revenue Actual 18.00M 354.50M 9.46M 9.46M

To track all earnings releases for Arcus Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings